National Institute on Drug Abuse; Notice of Closed Meeting, 385-386 [E9-31142]
Download as PDF
Federal Register / Vol. 75, No. 2 / Tuesday, January 5, 2010 / Notices
National Cancer Institute (NCI)
Enterprise Vocabulary Services (EVS) to
improve the problem codes. The goals of
this initiative are to streamline the
patient and device problem codes,
integrate FDA’s problem codes into the
NCI Thesaurus and Meta-Thesaurus,
organize the vocabulary into a
hierarchical format, and provide
information that will assist reporters in
requesting new codes, such as a
mapping of inactivated or merged terms
to preferred terms.
II. Comments
Interested persons may submit to the
Division of Dockets Management (see
ADDRESSES) electronic or written
comments regarding this document.
Submit a single copy of electronic
comments or two paper copies of any
mailed comments, except that
individuals may submit one paper copy.
Comments are to be identified with the
docket number found in brackets in the
heading of this document. Received
comments may be seen in the Division
of Dockets Management between 9 a.m.
and 4 p.m., Monday through Friday.
Dated: December 11, 2009.
Jeffrey Shuren,
Acting Director, Center for Devices and
Radiological Health.
[FR Doc. E9–31197 Filed 1–4–10; 8:45 am]
BILLING CODE 4160–01–S
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Office of the Director, National
Institutes of Health; Notice of Meeting
srobinson on DSKHWCL6B1PROD with PROPOSALS
Pursuant to section 10(a) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of a meeting of the
Advisory Committee to the Director,
NIH.
The meeting will be open to the
public. Individuals who plan to listen to
this teleconference should notify the
Contact Person listed below in advance
of the meeting.
Name of Committee: Advisory Committee
to the Director, NIH.
Date: January 22, 2010.
Time: 10:45 a.m. to 11:45 a.m., Eastern
Standard Time.
Place: National Institutes of Health, 1
Center Drive, Bethesda, MD 20892.
Agenda: ACD Working Group Report on
Stem Cells (Telephone Conference Call).
Contact Person: Penny Wung Burgoon,
PhD, National Institutes of Health, 1 Center
Drive, Building 1, Room 109, Bethesda, MD
20892, 301–451–5870, burgoonp@od.nih.gov.
VerDate Nov<24>2008
16:41 Jan 04, 2010
Jkt 220001
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and, when
applicable, the business or professional
affiliation of the interested person.
Information is also available on the Office
of the Director’s home page: https://
www.nih.gov/about/director/acd.htm, where
an agenda and any additional information for
the meeting will be posted when available.
Dated: December 29, 2009.
Anna Snouffer,
Deputy Director, Office of Federal Advisory
Committee Policy.
[FR Doc. E9–31233 Filed 1–4–10; 8:45 am]
385
Contact Person: Francois Boiler, MD, PhD,
Scientific Review Officer, Division of
Extramural Activities, National Institute of
Mental Health, NIH, Neuroscience Center,
6001 Executive Blvd., Room 6142, MSC 9606,
Bethesda, MD 20892–9606, 301–443–1513,
bollerf@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.242, Mental Health Research
Grants; 93.281, Scientist Development
Award, Scientist Development Award for
Clinicians, and Research Scientist Award;
93.282, Mental Health National Research
Service Awards for Research Training,
National Institutes of Health, HHS)
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Dated: December 23, 2009.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. E9–31143 Filed 1–4–10; 8:45 am]
BILLING CODE 4140–01–M
National Institutes of Health
National Institute of Mental Health;
Notice of Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Mental Health, Special Emphasis Panel K99.
Date: January 28, 2010.
Time: 10 a.m. to 3 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Neuroscience Center, 6001 Executive
Boulevard, Rockville, MD 20852 (Telephone
Conference Call).
Contact Person: Megan Libbey, PhD,
Scientific Review Officer, Division of
Extramural Activities, National Institute of
Mental Health, NIH, Neuroscience Center,
6001 Executive Blvd., Room 6148, MSC 9609,
Rockville, MD 20852–9609, 301–402–6807.
libbeym@mail.nih.gov.
Name of Committee: National Institute of
Mental Health Special Emphasis Panel Conte
Center Review.
Date: February 26, 2010.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: The Mandarin Oriental, 1330
Maryland Avenue, SW., Washington, DC
20024.
PO 00000
Frm 00050
Fmt 4703
Sfmt 4703
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute on Drug Abuse;
Notice of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Drug Abuse Special Emphasis Panel;
Substance Use and Abuse Among U.S.
Military Personnel, Veterans, and their
Families.
Date: March 9–10, 2010.
Time: 9 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: The Dupont Hotel, 1500 New
Hampshire Avenue, NW., Washington, DC
20036.
Contact Person: Nadine Rogers, PhD,
Scientific Review Administrator, Office of
Extramural Affairs, National Institute on
Drug Abuse, NIH, DHHS, Room 220, MSC
8401, 6101 Executive Boulevard, Bethesda,
MD 20892–8401, 301–402–2105,
rogersn2@nida.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.279, Drug Abuse and
Addiction Research Programs, National
Institutes of Health, HHS)
E:\FR\FM\05JAN1.SGM
05JAN1
386
Federal Register / Vol. 75, No. 2 / Tuesday, January 5, 2010 / Notices
Dated: December 24, 2009.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. E9–31142 Filed 1–4–10; 8:45 am]
ACTION:
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2009–N–0667]
[FDA 225–09–007]
Memorandum of Understanding
Between the United States Department
of Health and Human Services, Food
and Drug Administration, Center for
Drug Evaluation and Research and
Northeastern University
AGENCY:
Food and Drug Administration,
srobinson on DSKHWCL6B1PROD with PROPOSALS
HHS.
VerDate Nov<24>2008
16:41 Jan 04, 2010
Jkt 220001
Notice.
DATES: The agreement became effective
November 19, 2009.
SUMMARY: The Food and Drug
Administration (FDA) is providing
notice of a Memorandum of
Understanding (MOU) between FDA
and Northeastern University. The
purpose of the MOU is to form a
collaborative relationship between FDA
and Northeastern University; provide
opportunities for exchanging of graduate
and undergraduate students, faculty,
and personnel and for advanced training
and outreach; stimulate cooperative
research, and information exchange in
biological product characterization and
regulation with Northeastern
University’s Barnett Institute of
Chemical and Biological Analysis; and
develop training programs for FDA and
potentially other Government agencies
and Industry in the broad areas of
biotechnology and analytical chemistry.
PO 00000
Frm 00051
Fmt 4703
Sfmt 4703
FOR FURTHER INFORMATION CONTACT:
Keith O. Webber, Office of
Pharmaceutical Science, Center for Drug
Evaluation and Research, Food and
Drug Administration, 10903 New
Hampshire Ave., Silver Spring, MD
20903, 301–796–2400, e-mail:
Keith.webber@fda.hhs.gov.
In
accordance with 21 CFR 20.108(c),
which states that all written agreements
and MOUs between FDA and others
shall be published in the Federal
Register, the agency is publishing notice
of this MOU.
SUPPLEMENTARY INFORMATION:
Dated: December 17, 2009.
David Dorsey,
Acting Deputy Commissioner for Policy,
Planning and Budget.
BILLING CODE 4160–01–S
E:\FR\FM\05JAN1.SGM
05JAN1
Agencies
[Federal Register Volume 75, Number 2 (Tuesday, January 5, 2010)]
[Notices]
[Pages 385-386]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E9-31142]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute on Drug Abuse; Notice of Closed Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of the following
meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute on Drug Abuse Special
Emphasis Panel; Substance Use and Abuse Among U.S. Military
Personnel, Veterans, and their Families.
Date: March 9-10, 2010.
Time: 9 a.m. to 5 p.m.
Agenda: To review and evaluate grant applications.
Place: The Dupont Hotel, 1500 New Hampshire Avenue, NW.,
Washington, DC 20036.
Contact Person: Nadine Rogers, PhD, Scientific Review
Administrator, Office of Extramural Affairs, National Institute on
Drug Abuse, NIH, DHHS, Room 220, MSC 8401, 6101 Executive Boulevard,
Bethesda, MD 20892-8401, 301-402-2105, rogersn2@nida.nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.279, Drug
Abuse and Addiction Research Programs, National Institutes of
Health, HHS)
[[Page 386]]
Dated: December 24, 2009.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. E9-31142 Filed 1-4-10; 8:45 am]
BILLING CODE 4140-01-M